Clinical Trial Detail

NCT ID NCT04019964
Title Nivolumab in Biochemically Recurrent dMMR Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

prostate cancer

Therapies

Nivolumab

Age Groups: senior adult

Additional content available in CKB BOOST